Clinical Trials
12 trialsNCT05075603 2025-10-23
Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy
NeoImmuneTech
Phase 1 Completed
NCT03568461 2025-10-07
ELARA
Novartis
Phase 2 Completed
NCT04890236 2025-01-20
Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study
Emory University
Phase EARLY_PHASE1 Completed
NCT03610724 2024-06-20
BIANCA
Novartis
Phase 2 Completed
NCT02445248 2024-04-18
JULIET
Novartis
Phase 2 Completed
NCT02435849 2024-02-13
ELIANA
Novartis
Phase 2 Completed
NCT05541328 2022-09-15
Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel
Novartis
Completed
NCT03630159 2022-08-15
PORTIA
Novartis
Phase 1 Completed
NCT05349201 2022-07-01
CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)
Novartis
Completed
NCT02529813 2022-06-30
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03123939 2021-07-21
Phase III B in Acute Lymphoblastic Leukemia
Novartis
Phase 3 Completed
NCT02228096 2020-11-23
ENSIGN
Novartis
Phase 2 Completed